U.S. Antipsychotic Drugs Market Size, Share and Growth Forecast for 2024 - 2031

Table of Content

1. Executive Summary
    1.1. Antipsychotic Drugs Market Snapshot, 2024 and 2031
    1.2. Market Opportunity Assessment, 2023 - 2031, US$ Bn
    1.3. Key Market Trends
    1.4. Future Market Projections
    1.5. Premium Market Insights
    1.6. Industry Developments and Key Market Events
    1.7. PMR Analysis and Recommendations
2. Market Overview
    2.1. Market Scope and Definition
    2.2. Market Dynamics
        2.2.1. Drivers
        2.2.2. Restraints
        2.2.3. Opportunity
        2.2.4. Challenges
        2.2.5. Key Trends
    2.3. Macro-Economic Factors
        2.3.1. U.S. Sectorial Outlook
        2.3.2. U.S. GDP Growth Outlook
        2.3.3. U.S. Healthcare Spending Outlook
    2.4. COVID-19 Impact Analysis
    2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
    3.1. Value Chain Analysis
        3.1.1. List of Distribution Channel/Marketplaces
            3.1.1.1. Retail
            3.1.1.2. Audiology
            3.1.1.3. E-Commerce
        3.1.2. List of End User (Industry)
    3.2. Key Deals and Mergers
    3.3. PESTLE Analysis
    3.4. Porter’s Five Force Analysis
4. U.S. Antipsychotic Drugs Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
    4.1. Key Highlights
        4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
        4.1.2. Absolute $ Opportunity
    4.2. Market Size (US$ Bn) Analysis and Forecast
        4.2.1. Historical Market Size (US$ Bn) Analysis, 2018-2022
        4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
    4.3. U.S. Antipsychotic Drugs Market Outlook: Therapeutic Class
        4.3.1. Introduction / Key Findings
        4.3.2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Class, 2018-2022
        4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Class, 2023-2031
            4.3.3.1. First Generation
            4.3.3.2. Second Generation
            4.3.3.3. Third Generation
    4.4. Market Attractiveness Analysis: Therapeutic Class
    4.5. U.S. Antipsychotic Drugs Market Outlook: Application
        4.5.1. Introduction / Key Findings
        4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2018-2022
        4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023-2031
            4.5.3.1. Schizophrenia
            4.5.3.2. Dementia
            4.5.3.3. Bipolar Disorder
            4.5.3.4. Depression
            4.5.3.5. Others
    4.6. Market Attractiveness Analysis: Application
    4.7. U.S. Antipsychotic Drugs Market Outlook: Distribution Channel
        4.7.1. Introduction / Key Findings
        4.7.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2018-2022
        4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2023-2031
            4.7.3.1. Hospital Pharmacies
            4.7.3.2. Retail Pharmacies
            4.7.3.3. Online Pharmacies
    4.8. Market Attractiveness Analysis: Distribution Channel
5. Competition Landscape
    5.1. Market Share Analysis, 2023
    5.2. Market Structure
        5.2.1. Competition Intensity Mapping By Market
        5.2.2. Competition Dashboard
    5.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
        5.3.1. Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
            5.3.1.1. Overview
            5.3.1.2. Segments and Type
            5.3.1.3. Key Financials
            5.3.1.4. Market Developments
            5.3.1.5. Market Strategy
        5.3.2. Teva Pharmaceutical Industries Ltd.
        5.3.3. Eli Lilly and Company
        5.3.4. Dr. Reddy's Laboratories Limited
        5.3.5. AstraZeneca PLC.
        5.3.6. Johnson & Johnson (Janssen Pharmaceuticals)
        5.3.7. Pfizer Inc.
        5.3.8. Alkermes Plc.
        5.3.9. AbbVie Inc. (Allergan Inc.)
        5.3.10. Bristol-Myers Squibb
6. Appendix
    6.1. Research Methodology
    6.2. Research Assumptions
    6.3. Acronyms and Abbreviations

Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

List Of Table

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

Get a Customized Version

- List Of Chart -